Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Lion

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|March 7, 2022
Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by <i>In Situ</i> Silencing of Programmed-Death LigandsMaarten Versteven, Donovan Flumens, Diana Campillo-Davó, et al.
Pharmaceutics|May 4, 2026
Increasing Transfection of Human Monocyte-Derived Dendritic Cells by Optimizing Lipid Nanoparticle Ionizable Lipid and mRNA Uridine ModificationIzabella Lambart, Daniel Flender, Dana Liu, et al.
Frontiers in Immunology|November 23, 2018
Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR MispairingDiana Campillo-Davo, Fumihiro Fujiki, Johan M J Van den Bergh, et al.
Plos One|July 15, 2024
Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC studyJolien Van den Bossche, Maxime De Laere, Koen Deschepper, et al.
Cancer Immunology Research|June 23, 2017
Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell ExpansionJohan M J Van den Bergh, Evelien L J M Smits, Zwi N Berneman, et al.
STAR Protocols|February 28, 2023
In vitro expansion of Wilms' tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cellsSanne van der Heijden, Donovan Flumens, Maarten Versteven, et al.
Journal of Cellular and Molecular Medicine|July 1, 2014
HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cellsJohan M J Van den Bergh, Khadija Guerti, Yannick Willemen, et al.
Annals of Hematology|September 11, 2024
Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsedSofie Gielis, Donovan Flumens, Sanne van der Heijden, et al.
Cancers|October 23, 2019
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer CellsJinthe Van Loenhout, Tal Flieswasser, Laurie Freire Boullosa, et al.
Oncotarget|January 19, 2017
Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cellsHeleen H Van Acker, Ottavio Beretta, Sébastien Anguille, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|March 7, 2022
Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by <i>In Situ</i> Silencing of Programmed-Death LigandsMaarten Versteven, Donovan Flumens, Diana Campillo-Davó, et al.
Pharmaceutics|May 4, 2026
Increasing Transfection of Human Monocyte-Derived Dendritic Cells by Optimizing Lipid Nanoparticle Ionizable Lipid and mRNA Uridine ModificationIzabella Lambart, Daniel Flender, Dana Liu, et al.
Frontiers in Immunology|November 23, 2018
Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR MispairingDiana Campillo-Davo, Fumihiro Fujiki, Johan M J Van den Bergh, et al.
Plos One|July 15, 2024
Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC studyJolien Van den Bossche, Maxime De Laere, Koen Deschepper, et al.
Cancer Immunology Research|June 23, 2017
Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell ExpansionJohan M J Van den Bergh, Evelien L J M Smits, Zwi N Berneman, et al.
STAR Protocols|February 28, 2023
In vitro expansion of Wilms' tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cellsSanne van der Heijden, Donovan Flumens, Maarten Versteven, et al.
Journal of Cellular and Molecular Medicine|July 1, 2014
HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cellsJohan M J Van den Bergh, Khadija Guerti, Yannick Willemen, et al.
Annals of Hematology|September 11, 2024
Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsedSofie Gielis, Donovan Flumens, Sanne van der Heijden, et al.
Cancers|October 23, 2019
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer CellsJinthe Van Loenhout, Tal Flieswasser, Laurie Freire Boullosa, et al.
Oncotarget|January 19, 2017
Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cellsHeleen H Van Acker, Ottavio Beretta, Sébastien Anguille, et al.
Pageof 7